Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 67 citing articles:

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
Andrea Kaifie, Martin Kirschner, Dominik Wolf‎, et al.
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 169
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
Valerio De Stefano, Marco Ruggeri, Francisco Cervantes, et al.
Leukemia (2016) Vol. 30, Iss. 10, pp. 2032-2038
Open Access | Times Cited: 86
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
Sam Schulman
Blood (2017) Vol. 129, Iss. 25, pp. 3285-3293
Open Access | Times Cited: 53
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease
Joan How, Amy Zhou, Stephen T. Oh
Therapeutic Advances in Hematology (2016) Vol. 8, Iss. 3, pp. 107-118
Open Access | Times Cited: 51
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, et al.
Clinical Medicine Insights Blood Disorders (2020) Vol. 13
Open Access | Times Cited: 43
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)
Iris Appelmann, Stephan Kreher, Stefani Parmentier, et al.
Annals of Hematology (2016) Vol. 95, Iss. 5, pp. 707-718
Closed Access | Times Cited: 41
An Overview of Thrombophilia and Associated Laboratory Testing
Martina Montagnana, Giuseppe Lippi, Elisa Danese
Methods in molecular biology (2017), pp. 113-135
Closed Access | Times Cited: 40
Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved
Vikas Bhuria, Conny K. Baldauf, Burkhart Schraven, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3206-3206
Open Access | Times Cited: 21
Heparanase procoagulant activity in cancer progression
Yona Nadir, Benjamin Brenner
Thrombosis Research (2016) Vol. 140, pp. S44-S48
Closed Access | Times Cited: 32
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Tiziano Barbui, Valerio De Stefano, Anna Falanga, et al.
Blood Cancer Journal (2019) Vol. 9, Iss. 8
Open Access | Times Cited: 31
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
Hassan Awada, Maria Teresa Voso, Paola Guglielmelli, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1746-1746
Open Access | Times Cited: 29
New horizons in subdural haematoma
Frances Rickard, John Gale, Adam Williams, et al.
Age and Ageing (2023) Vol. 52, Iss. 12
Closed Access | Times Cited: 11
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria
Steffen Koschmieder, Jens Panse
Hämostaseologie (2025)
Closed Access
Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry
Hyunyee Rosa Cho, Susanne Isfort, Kim Kricheldorf, et al.
HemaSphere (2025) Vol. 9, Iss. 3
Open Access
Pathophysiology of Trousseau’s syndrome
Christina Dicke, Florian Länger
Hämostaseologie (2014) Vol. 35, Iss. 01, pp. 52-59
Closed Access | Times Cited: 31
JAK-2 V617F mutation increases heparanase procoagulant activity
Inna Kogan, Dafna Chap, Ron Hoffman, et al.
Thrombosis and Haemostasis (2015) Vol. 115, Iss. 01, pp. 73-80
Closed Access | Times Cited: 30
High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation
Kai Wille, Parvis Sadjadian, Tatjana Becker, et al.
Annals of Hematology (2018) Vol. 98, Iss. 1, pp. 93-100
Closed Access | Times Cited: 29
Head injury in the elderly – an overview for the physician
William Beedham, George Peck, Simon Richardson, et al.
Clinical Medicine (2019) Vol. 19, Iss. 2, pp. 177-184
Open Access | Times Cited: 26
Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?
Lorenzo Falchi, Prithviraj Bose, Kate J. Newberry, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 352-364
Open Access | Times Cited: 27
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry
Judith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4086-4086
Open Access | Times Cited: 20
Complications and management of coagulation disorders in leukemia patients
Deepesh Lad, Arihant Jain, Subhash Varma
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 61-72
Open Access | Times Cited: 23
Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery
Sarah Chuzi, Brady L. Stein
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 58, Iss. 12, pp. 2786-2798
Closed Access | Times Cited: 22
From leeches to personalized medicine: evolving concepts in the management of polycythemia vera
Alessandro M. Vannucchi
Haematologica (2016) Vol. 102, Iss. 1, pp. 18-29
Open Access | Times Cited: 20
Thrombotic, Cardiovascular, and Microvascular Complications of Myeloproliferative Neoplasms and Clonal Hematopoiesis (CHIP): A Narrative Review
Andrew I. Schafer, Douglas L. Mann
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6084-6084
Open Access | Times Cited: 2
Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?
M Lamy, Paola Palazzo, Pierre Agius, et al.
Cerebrovascular Diseases (2017) Vol. 44, Iss. 3-4, pp. 97-104
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top